Abstract:Background: The programmed cell death 1 (PD-1)/PD-1 ligand 1 (PD-L1) signaling pathway is significantly upregulated in severe influenza virus infection, which impairs the immune system and causes increased tissue inflammation and damage. Blocking this signaling pathway will reduce the damage, lower the virus titer in lung tissue, and alleviate the symptoms of infection to promote recovery. The aim of this study was to identify the key factors and regulatory mechanisms in the PD-1 checkpoint blockade–responsive immune microenvironment in severe influenza infection. Methods: A BALB/c mouse model of severe influenza A/H1N1 infection was constructed, and whole-transcriptome sequencing of mice treated with PD-1 checkpoint blockade before severe A/PR8(H1N1) influenza infection and IgG2a isotype control before infection were performed. Subsequently, the differential expression of nucleic acids between these two groups was analyzed, followed by functional interaction prediction analysis to investigate gene-regulatory circuits. Results: In total, 84 differentially expressed (dif) mRNAs, 36 dif-microRNAs (miRNAs), 90 dif‑lncRNAs (long noncoding RNAs), and 22 dif-circRNAs (circular RNAs) were found in PD-1 antagonist treated A/PR8(H1N1) influenza infection lung compared with the controls (IgG2a isotype control treated before infection). In spleens between the above two groups, 45 dif-mRNAs, 36 dif-miRNAs, 57 dif-lncRNAs, and 24 dif-circRNAs were identified. Direct function enrichment analysis of dif-mRNAs and dif-miRNAs showed that these genes were mainly involved in myocardial damage related to viral infection, mitogen activated protein kinase (MAPK) signaling pathways, RAP1 (Ras-related protein 1) signaling pathway, and Axon guidance. Finally, 595 interaction pairs were obtained for the lungs and 462 interaction pairs for the spleen were obtained in the competing endogenous RNA (ceRNA) complex network, in which the downregulated mmu‑miR-7043-3p and Vps39-204 were enriched significantly. Conclusions: The present study provided a basis for the identification of potential pathways and hub genes that might be involved in the PD-1 checkpoint blockade–responsive immune microenvironment in severe influenza infection.

Critical role of oxidized LDL receptor-1 in intravascular thrombosis in a severe influenza mouse model

Bioinformatic analysis of PD 1 checkpoint blockade responsive immune microenvironment in severe influenza infection

STAT1 regulates neutrophil gelatinase B-associated lipocalin induction in influenza-induced myocarditis

Influenza Causes MLKL-Driven Cardiac Proteome Remodeling During Convalescence

Plasma surfactant proteins and lipid mediators in the airway associate with different stages of viral infection and resolution in a sub-lethal mouse Influenza A model

Delayed Angiopoietin‐2 Blockade Reduces Influenza‐induced Lung Injury and Improves Survival in Mice

Tpl2 Ablation Leads to Hypercytokinemia and Excessive Cellular Infiltration to the Lungs During Late Stages of Influenza Infection

Kinetics of Pulmonary Immune Cells, Antibody Responses and Their Correlations with the Viral Clearance of Influenza A Fatal Infection in Mice

Critical role of CXCL4 in the lung pathogenesis of influenza (H1N1) respiratory infection

IL-36 receptor deletion attenuates lung injury and decreases mortality in murine influenza pneumonia

The Θ-Defensin Retrocyclin 101 Inhibits TLR4- and TLR2-dependent Signaling and Protects Mice Against Influenza Infection.

Heme oxygenase‐1 regulates the immune response to influenza virus infection and vaccination in aged mice

Oxygen Free Radical Involvement In Acute Lung Injury Induced By H5n1 Virus In Mice

Cell-intrinsic regulation of phagocyte function by interferon lambda during pulmonary viral, bacterial super-infection

Changes in the Expression of Proteins Associated with Neurodegeneration in the Brains of Mice after Infection with Influenza A Virus with Wild Type and Truncated NS1

C-Reactive Protein Mediating Immunopathological Lesions: A Potential Treatment Option for Severe Influenza A Diseases

The TLR4 antagonist Eritoran protects mice from lethal influenza infection

Severity of neonatal influenza infection is driven by type I interferon and oxidative stress

AIM2 Inflammasome is Critical for Influenza-Induced Lung Injury and Mortality.

Detrimental Contribution of the Toll-Like Receptor (TLR)3 to Influenza A Virus–Induced Acute Pneumonia

Damage sensing through TLR9 Regulates Inflammatory and Antiviral Responses During Influenza Infection